An investigation into spiked dietary supplements has the attention of industry groups.
In response to aNew York Times exposé on tainted dietary supplements in the U.S. marketplace, the Natural Products Association is reassuring the public that laws are already in place to prosecute illegal product manufacturers and that FDA already has plenty authority to enforce those laws.
The New York Times story, published on August 27, kicks off with a claim that "there is little evidence that many dietary supplements provide real health benefits." The article moves on to a central issue of illegal substances, including sildenafil (used to treat erectile dysfunction) and sibutramine (an appetite suppressant for weight loss), being marketed to U.S. consumers in the form of dietary supplements.
The author blames the ongoing spiking issue on a lack of industry self-regulation:
Industry representatives say a vast majority of supplements are safe, and they fault regulators for failing to stop the influx of illegal products from places like China. But few seem willing to tackle the problem openly. Unlike, say, the fashion industry, which has lobbied for increased regulation to combat knock-off products and has vociferously publicized the issue, the supplement industry is at best waging a whisper campaign.
On Friday, John Gay, executive director and CEO of the Natural Products Association (Washington, DC), publishes his own thoughts on the matter:
The Food and Drug Administration has all the authority it needs to regulate dietary supplements thanks to [the Dietary Supplement Health and Enforcement Act]. For example, the FDA requires a pre-market safety notification process for any new dietary ingredient meant to be marketed in a supplement. In addition, structure-function claims or health claims about supplements must be submitted to the FDA with a copy of the product label. Claims that are not truthful and misleading can result in regulatory action from either the FDA or the Federal Trade Commission. The FDA also can remove products from store shelves that it deems to be a health risk. Anyone caught selling drugs that masquerade as supplements should be prosecuted to the fullest extent of the law. Selling products containing illegal substances is a crime. It is also illegal for any manufacturer to claim that their dietary supplements prevent, mitigate, cure or treat any disease condition. We urge anyone finding dietary supplements that are incorrectly labeled to report this to the FDA.
Arla Foods to acquired whey nutrition business from Volac International
April 22nd 2024Arla Foods Ingredients has reached an agreement to acquire Volac’s Whey Nutrition business through a purchase of shares in Volac Whey Nutrition Holdings Limited and its subsidiary, Volac Whey Nutrition Limited and Volac Renewable Energy Limited.
The Nutritional Outlook Podcast Episode 29: 2024 Ingredients to Watch
January 31st 2024Nutritional Outlook interviews Scott Dicker, market insights director from market researcher SPINS, about ingredients and product categories nutraceutical and nutrition product manufacturers should watch in 2024.
The 2023 Supplement Consumer: Immune Health and Beyond
April 19th 2024Did you know two-out-of-three U.S. supplement consumers say their immune health has become more important to them, yet only 38% would describe their immune health as “very healthy?” There’s an opportunity to meet consumers in their growing desire to live healthier lifestyles and help them redefine resilience. IMMUSETM is the universal postbiotic for year-round immune support. Unlock exclusive consumer insights and discover the formulation opportunities with IMMUSETM with this consumer research.